Narrow Results

Changes such as expiring patents and shifting environments challenge a firm trying to reach long-lasting appropriation success of an innovation. To understand how appropriation can be continued over time, this study investigates and compares Bayer’s two innovations, Aspirin medicine and Roundup herbicide. Whereas for the first, appropriation success has been continued through decades, for the latter, such a continuum has not realised. Our findings suggest that long-lasting appropriation success lies in adjusting the appropriation strategy by identifying the most substantial appropriability premises for innovation (appropriability mechanisms and complementary assets) and the ways to use them in different situations, paying specific attention to the shifting appropriability conditions. For long-term success, it is critical for firms to recognise that isolating appropriability mechanisms and complementary assets can have varied and distinctive implications depending on the pertinent contextual factors at innovation level and to strategise accordingly.

NUS Researchers Create Palm-Size Device for Quick, Effective Treatment of Common Hearing Disorder.

World Asthma Day: Managing and Living with Asthma.

DARZALEX^® (daratumumab) Available in Singapore, Following Accelerated Approval by the Health Sciences Authority.

Managing Liver Cancer as a Global Health Problem.

Bayer and NUS Enterprise Announce Winners of Grants4Apps^® Singapore Open Innovation Challenge.

Exclusive Interviews with the Grants4Apps^® winners: I. EyeDEA, Singapore, II. GlycoLeap by Holmusk, Singapore and III. PillPocket, Thailand.

Panvax’s Foot-and-Mouth Vaccine Program.

Agenix’s ThromboView Phase Ia Blood Clot Trial Successful.

Sino-Australian Joint Venture Established.

Beijing Deweizhi’s Latest Drug Procurement Agreement.

Shandong Enterprises Collaborate with Beijing Universities.

Shandong Qilu Pharmaceutical Launches Indobufen Tablets.

Domestic AIDS Drug Cleared For Marketing.

Azithromycin Powder Marketed by Zhejiang Kangyu.

Trial Reforms in Zhejiang Drug Distribution Industry.

Anti-Cancer Drug Enters Phase II Clinical Trials.

Bioway’s Nerve Growth Factor Put into Production.

Latest Drug Delivery Center in Operation.

Metahelix Signs Genome Research Deal with ViaLactia Biosciences.

AstraZeneca Seeks Exclusive Marketing Rights for New Drugs in India.

Imaging Technology Utilized in Meat Contaminant Screening.

Inproser Launches In’novase Project in Malaysia.

Asia’s First Human Insulin Plant.

World’s Smallest Heart Pump Undergoing Clinical Trial.

Kaohxiong Biological Product Co. Signs Distribution Agreement with Bayer.

Agilent Technologies Expands Mass Spectrometry Portfolio with New MS Instruments and Proteomics Software.

Increased Collaboration among Indian Biotech Giants.

BAYER HealthCare and Economic Development Board to foster translational and clinical research for diseases prevalent in Asia

Ludwig Cancer Research and University of Oxford launch Cancer Immunotherapy Spinout

OmniComm Systems® Announces Reseller Agreement with Tri-I Biotech Shanghai Inc. Market Leading Life Sciences Consultancy to Resell OmniComm’s TrialOne® eSource Solution

Resverlogix Closes License Agreement and Enters Into Definitive Stock Purchase Agreement with Hepalink

Immunovaccine and PharmAthene Sign Exclusive Worldwide License Agreement to Develop and Commercialize an Anthrax Vaccine Formulated in DepoVax™

Commonwealth Financing Authority Announces New Alternative, Clean Energy Investment

ContraFect Corporation Announces Issuance of Key Patent Covering Novel Lysin Technology

M Pharmaceutical Inc. Rebrands Itself to Better Reflect Growing Family of Biomedical Technologies

Sustainable Apparel Coalition Recognizes SCS Global Services as Approved Verifier for New Pilot Program

StemCell United Announces Plans for PO and Listing on ASX

Roche Diagnostics Strengthens Footprint in Asia Pacific

Efficient Light-Harvesting of Plants: Conversation with Professor Alexander Ruban.

Takeda Pharmaceuticals in the Emerging Markets.

Burden of Thrombosis-related Diseases in Asia-Pacific.

GE Healthcare's Cell Culture Media Facility in Singapore.

Waste Management in Singapore: Where Does Our Rubbish Go?

Partnership with Bayer Addressing Healthcare Needs.

Exploring the Factors behind Heart Failure Disease in Asia.

Tobacco Harm Reduction and Reduced-Risk Products.

BIOTRONIK Begins Manufacturing High-Tech Products in Singapore.

First Dengue Vaccine Approved in More than 10 Countries.

Zyrtec^® Tablet for Allergy Relief, Now Available Over-the-Counter as Zyrtec^®-R Tablet.

Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Three Years Running.

First Pan-Asian Real-world Study on the Use of Rivaroxaban for Stroke Prevention in Patients with Atrial Fibrillation.

Oxford Spinout to Develop Cancer Therapies which Reprogram Tumours to Die.

Recruitment Begins for Major Clinical Study in Precision Therapy for Liver Cancer Patients.

GE Healthcare opens USD 7.4 million APAC Fast Trak Bioprocessing Technology and Training Center in South Korea.

Regional Experts Urging Stakeholder Collaboration to Address Burden of Osteoporosis at IOF 6th Asia-Pacific Meeting

Cardinal Health Announces New Strategic Distribution Agreements to Expand Cordis’ Cardiovascular Product Offerings in Asia Pacific

Exco InTouch Granted US Patent for Its Ground-breaking Mobile Health Solutions

GE Healthcare and Valneva Collaboration Delivers Optimized Cell Culture Medium for Vaccine Production

Singapore's Restalyst Develops More Effective Test Kit for Liver Cancer

Bayer Collaborates with Singapore National Eye Centre to Take the Lead in Professional Development of Ophthalmologists Across Asia

Partnerships and Innovation: Shaping the Future of Healthcare in Asia Pacific

Chugai's Novel Antibody Technologies Put Singapore at the Centre of Fight Against Disease

NCCS AND SGH Conducts Systematic Molecular Profiling of Lung Cancers to Identify New Treatment Opportunities

Vascular Dynamics receives FDA approval to begin conclusive and pivotal trial experimentation for treatment of chronic hypertension.

Orchard Therapeutics’ OTL-101 granted Promising Innovative Medicine Designation for treatment of ADA-SCID.

Concept Life Sciences appoints John Handley as chief operating officer.

Oak Therapeutics completes Phase 1 of NIH grant to develop formulation for tuberculosis.

Relvar Ellipta significantly improves asthma control compared with usual care medicines.

Hematological disorders to benefit from significant level of first-in-class innovation.

Boehringer Ingelheim initiates Phase IIa study of Pharmaxis compound for treating NASH.

Ambrosus partners with Trek Therapeutics to develop blockchain method to track quality in pharmaceutical manufacturing.

Bosch subsidiary Valicare offers consulting in GMP-compliant development of cancer therapies.

Korea-Singapore Healthcare Incubator to support Korean firms in Singapore and Southeast Asia.

Newer oral anticoagulant recommended for reducing risk of stroke in patients with irregular heartbeats.

Korean start-up Sky Labs selected as one of the winners for Bayer Grants4Apps Accelerator.

Supplement: Could COMPASS be a game changer in managing stable artery disease?

Supplement: Global study confirms positive benefit-risk profile of rivaroxaban for stroke prevention.

The following topics are under this section:

• AUM Biosciences obtains global rights to novel targeted cancer therapy
• Vitafoods Asia Conference to present top 5 APAC nutraceutical trends
• Weight Loss Made Simple – MyDoc Launches Medically supervised LivingLite™, in Singapore and the region
• Taiwan boosts development of biomedical industry through memorandums promoting a next-generation biomedical research ecosystem
• Mount Alvernia Hospital appoints ICON SOC to build new state-of-theart integrated cancer centre
• Healthy Hearts, Healthy Aging Asia Pacific report calls for specific policy actions and focus in managing cardiovascular disease
• Anticancer agent Halaven approved for treatment of locally advanced or metastatic breast cancer in China
• Advent Access receives CE Mark certificate for pioneering av-Guardian™ vascular access system
• ACT Genomics opens third laboratory in Asia at Hong Kong Science Park
• GSK opens new state-of-the-art pharmaceutical manufacturing facility in Singapore
• Taiwan Protein Project successfully enhances Taiwan' biotechnology R&D industry
• S$6.4 million boost for NUHS to push Artificial Intelligence (AI) in Healthcare Efficiency and Outcome
• HKUST Researchers Co-Discover a Novel Function of an Enzyme Offering Insight into the Pathology of Hereditary Spastic Paraplegia

The following topics are under this section:

• Preterm Births? Diet not the only answer
• The key in diagnosis and treatment
• Tackling Antimicrobial Resistance
• Clinical research studies pave the way for better healthcare
• Up in the Clouds with Artificial Intelligence and Healthcare

The following topics are under this section:

• Boston-based Singapore start-up gains FDA approval for AI-powered analytics engine for physiological monitoring
• Singapore’s first private co-working laboratory and office space
• Research partnership between Bayer and RIKEN innovation to boost drug discovery opportunities
• Digital healthcare company concludes initial round of training for licensed doctors to practice telemedicine in Southeast Asia.
• Australia’s largest start-up accelerator becomes Singapore’s first HealthTech accelerator
• Gilead Sciences, Inc. announces Biktarvy^® is now available via the National Health Insurance scheme in Taiwan
• Actinogen Medical demonstrates novel approach to treating cognitive impairment
• Singapore-based MedTech company announced as winner of 2019 Asia Pacific Showcase Competition at The MedTech Forum
• Three-dimensional model of blood vessel “on-a-chip”